This week’s biotechnology news headlines include, Roche breast cancer drug trial results, psoriasis drug meets end goal in studies, cancer drug meets main trial goal, AbbVie gets FDA approval for Crohn’s disease, biotech firms looking for biosimilars, and Johnson and Johnson to buy Alios BioPharma.
Cell Culture Events
2-Day Workshops on Modeling and Simulation in Biomanufacturing Operations
Bio-G is hosting 2-Day workshops around the country on Modeling and Simulation in Biomanufacturing Operations. Attendees work in hands-on sessions with the Bio-G Real-Time Modeling System (RTMS) to solve challenging manufacturing problems, including:
Roche Custom Biotech, AGU Industrial ITand Bayer Technologieswill be sharing and discussing their experience of applying modern cell culture monitoring and how this enables succinct quality by design(QbD) with focus on:
Solutions for reliable and precise measurements of a broad range of parameters taken from a small sample volume
Modern data management approach towards a paperless lab solution with a “Closed Loop”
Solutions for automated sampling, monitoring and storage in bio-pharmaceutical process development
Bioproduction – October 8-9, 2014 – Barcelo Sants Hotel – Barcelona, Spain
Conference: October 20-23, 2014, Exhibition: October 21-23, 2014
Hynes Convention Center, Boston, MA
Complete programming coverage of the full bioprocessing continuum – featuring 65 innovative case studies and 70 new data presentations intended for companies of all sizes and at every stage of development.
The world’s largest bioprocess exhibition – featuring over 150 exhibitors, lounges, and the BPI Theater with live product launches to help you plan future purchasing decisions.
Face-to-Face Networking opportunities that no other bioprocessing event can offer, plus access BPI’s event specific partnering tool to schedule meetings.
Featured Technology Workshops at BPI:
New Paradigms in Bioproduction – Culture Media Development, by William Whitford, Senior Manager, Hyclone Cell Culture, GE Healthcare Life Sciences. Tuesday October 21st 11:50 am
Guidelines for the Selection of Chromatography Media (Resins) and Steps to Meet Specific Purification Challenges, by Jonathan Royce, Senior Product Manager, Bioprocess Product Marketing – Downstream, GE Healthcare
“The Food and Drug Administration just granted permission for “expanded access” to an experimental medicine for Ebola. It’s OK as far as it goes, but it’s an exception to the FDA’s reluctance to approve the use of life-saving products.”
If you like this story, please see our blog titled “Highlights from IBC’s 4th Annual Cell Therapy Bioprocessing Conference”
“AbbVie has received approval from the US Food and Drug Administration (FDA) for Humira (adalimumab) to reduce signs and symptoms as well as achieve and maintain clinical remission, in pediatric Crohn’s disease patients six years of age and older.”
If you like this story, please see our blog titled “Flexible Facilities for Biopharmaceutical Manufacturing”
“Hundreds of companies around the world are chasing an emerging market for cheaper copies of costly biotech drugs, with more than 700 so-called biosimilars now in development or already approved, according to a major study of the sector.”
If you like this story, please see our blog titled “Cell Therapy for Parkinson’s Disease – Considerations for the Future”